C. V. Nissen, S. R. Wiegell, P. Philipsen, H. Wulf
{"title":"Short‐term chemical pretreatment cannot replace curettage in photodynamic therapy","authors":"C. V. Nissen, S. R. Wiegell, P. Philipsen, H. Wulf","doi":"10.1111/phpp.12236","DOIUrl":"https://doi.org/10.1111/phpp.12236","url":null,"abstract":"Guidelines for photodynamic therapy (PDT) recommend pretreatment with curettage/debulking to enhance intracellular formation of protoporphyrin IX (PpIX). However, studies suggest that new chemical pretreatment procedures may replace curettage/debulking.","PeriodicalId":20060,"journal":{"name":"Photodermatology","volume":"46 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2016-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"81012094","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Long‐term UVA eye irradiation causes decreased learning ability in mice","authors":"K. Hiramoto, E. Kasahara","doi":"10.1111/phpp.12229","DOIUrl":"https://doi.org/10.1111/phpp.12229","url":null,"abstract":"Long‐term eye radiation with ultraviolet A (UVA) denatures the cells of the cerebral hippocampus. However, the influence on memory and learning ability in mice is not known.","PeriodicalId":20060,"journal":{"name":"Photodermatology","volume":"17 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2016-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"81616225","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
K. Hiramoto, Y. Yamate, Daijiro Sugiyama, Yumi Takahashi, E. Mafune
{"title":"The gender differences in the inhibitory action of UVB‐induced melanocyte activation by the administration of tranexamic acid","authors":"K. Hiramoto, Y. Yamate, Daijiro Sugiyama, Yumi Takahashi, E. Mafune","doi":"10.1111/phpp.12231","DOIUrl":"https://doi.org/10.1111/phpp.12231","url":null,"abstract":"Tranexamic acid has an inhibitory action on ultraviolet (UV) B‐induced melanocyte activation. This study examined the sex differences in the inhibitory action of tranexamic acid on UVB‐induced melanocyte activation.","PeriodicalId":20060,"journal":{"name":"Photodermatology","volume":"2015 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2016-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"87778880","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Kasumi Lee, Y. Oda, Masanobu Sakaguchi, Akihisa Yamamoto, C. Nishigori
{"title":"Drug‐induced photosensitivity to bicalutamide – case report and review of the literature","authors":"Kasumi Lee, Y. Oda, Masanobu Sakaguchi, Akihisa Yamamoto, C. Nishigori","doi":"10.1111/phpp.12230","DOIUrl":"https://doi.org/10.1111/phpp.12230","url":null,"abstract":"Abstract Hormone therapy is highly important in the treatment of prostate cancer. Flutamide is used as an anti-androgen drug for prostate cancer; however, it has been reported that flutamide sometimes causes photosensitivity and severe liver dysfunction. In contrast, bicalutamide seldom causes these side-effects. Therefore, in recent years, flutamide has been replaced with bicalutamide as the most widely used anti-androgen drug for prostate cancer therapy. However, a few cases of photosensitivity caused by bicalutamide have been reported. Here, we present a case of photosensitivity caused by bicalutamide. This article is protected by copyright. All rights reserved.","PeriodicalId":20060,"journal":{"name":"Photodermatology","volume":"29 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2016-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"85195339","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Photoaggravated pompholyx","authors":"R. Nalluri, L. Rhodes","doi":"10.1111/phpp.12237","DOIUrl":"https://doi.org/10.1111/phpp.12237","url":null,"abstract":"To the Editor, Pompholyx is a type of eczema characterized by a pruritic vesicular eruption occurring on the lateral fingers, hands and feet (1, 2). Many aetiological factors such as atopy, contact allergy, adverse drug reactions, dermatophyte and HIV infection are reportedly associated, and stress, smoking, irritants and prolonged use of protective gloves are said to be aggravating factors (2). One of the important cutaneous adverse effects of intravenous immunoglobulin (IVIG) was pompholyx, which developed in 62.5% of the 64 patients who had eczematous reactions to IVIG (3). Hyperhidrosis may be an aggravating factor in up to 40% patients, and improvement has been observed after botulinum toxin A injections (4, 5). Pompholyx can be affected by seasonal changes, hot and cold temperatures, and is worse in summer as reported by a study in 6300 children aged 0-16 years in Turkey (1, 6). Interestingly, sunlight was reported to successfully treat pompholyx after failing ultraviolet A (UVA) therapy (7); however, the role of sunlight as an aetiological factor is rarely reported. We present 3 patients with the infrequently reported condition of photoaggravated pompholyx, with 2 of these showing positive provocation on phototesting.","PeriodicalId":20060,"journal":{"name":"Photodermatology","volume":"52 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2016-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"83970992","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Exploring the gaps in the evidence‐based application of narrowband UVB for the treatment of vitiligo","authors":"L. Madigan, M. Al-Jamal, I. Hamzavi","doi":"10.1111/phpp.12228","DOIUrl":"https://doi.org/10.1111/phpp.12228","url":null,"abstract":"While narrowband ultraviolet light B (NB‐UVB) has become integral to the treatment of diffuse vitiligo, evidence‐based guidelines have been lacking with regard to dosing and administration. This is largely the result of heterogeneous study designs, ambiguous methodologies, disparate dosing strategies, and the use of varied, and somewhat arbitrary, outcome measures. In the absence of prospective trials to address each of these concerns, the available literature regarding the application of NB‐UVB for vitiligo was reviewed and the authors now pose a set of questions to the phototherapy community in an attempt to highlight gaps within our understanding. We aim to stimulate discussion, elicit expert opinion, and identify areas for future research to move toward a unified and safe treatment guideline for patients afflicted by this disease.","PeriodicalId":20060,"journal":{"name":"Photodermatology","volume":"32 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2016-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"81899729","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Human immunodeficiency virus and risk of porphyria cutanea tarda: a possible association examined in a large hospital","authors":"P. Aguilera, M. Laguno, J. To-Figueras","doi":"10.1111/phpp.12222","DOIUrl":"https://doi.org/10.1111/phpp.12222","url":null,"abstract":"Human immunodeficiency virus (HIV) infection has been reported to be a risk factor for porphyria cutanea tarda (PCT).","PeriodicalId":20060,"journal":{"name":"Photodermatology","volume":"55 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2016-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"78903906","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}